CME Group Inc.(CME)Stock Price & Analysis
NASDAQ

CME Stock Price Today (October 2026) — CME Group Inc. Analysis & Key Metrics 2026-10-20

CME Group Inc. (CME) is trading at $295.31, up 0.61% today (as of October 2026). The stock continues to show sustained strength above key moving averages, attracting attention from investors looking for Financial Services growth opportunities.

  • According to consensus analyst estimates, the 1-year price target is $292.94 (0.8% downside).
  • Volatility is low (17.05% annualized), implying relatively contained price movements for short-term traders.
  • The fundamental picture, based on the latest financial filings, is nuanced: steady revenue (0.80% YoY) alongside competitive pressures in the Financial Data & Stock Exchanges space.

CME Stock Analysis: Key Metrics & Valuation (October 2026)

Concise, actionable data for investors

Trend posture
Uptrend: above 50- and 200-day averages
Analyst 1Y target$292.94-0.8%
Volatility (30d ann.)17.05%Low
RSI (14-day)
77.06 (Overbought)
Debt$3.87B (0.15x D/E)

CME Group Inc. - Historical Price & Volume

$295.31
+84.00 (+39.75%)
  • Price
  • Volume
  • Latest price
Range: 2Y

Market Cap

$106.19B

Enterprise Value: $107.78B

P/E Ratio

23.77

Forward P/E: 22.08

Revenue Growth

+0.80%

Year over Year

Analyst Target

$292.94

-0.8% downside from target

Key Investor Questions About CME

What investors need to know before buying

Is it a good time to buy CME stock?

Based on current market data, CME presents a overbought technical setup with mixed signals fundamentals.

  • Technicals say: Overbought (RSI 77.06)
  • Fundamentals say: Mixed signals (nuanced financial profile)
Can CME sustain revenue growth in the Financial Data & Stock Exchanges market?

CME's growth trajectory depends on its ability to expand within the Financial Data & Stock Exchanges sector while managing margin pressures.

  • Future growth will depend on performance in core Financial Data & Stock Exchanges operations.
  • The ability to manage competitive pressures will be crucial for sustained growth.
What are the biggest risks facing CME stock?

The primary risks for CME investors include debt exposure and competitive dynamics in the Financial Data & Stock Exchanges industry.

  • $3.87B in debt could be a headwind in a high-rate environment.
  • Fierce competition from established players in Financial Data & Stock Exchanges.

52-Week Trading Range

52-Week Low$218.31
52-Week High$329.16
Current Price$295.31

Over the past year, CME stock traded between $218.31 and $329.16 and currently trades in the middle of that range. Big swings are less likely unless a major catalyst emerges.

Volatility & Risk Profile

30-Day Volatility17.05%
Beta-0.37
RSI (14-day)77.06

With 17.05% annualized volatility and β=-0.37, the stock exhibits low sensitivity to market moves—making CME suitable for investors comfortable with active risk management.

Institutional & Insider Ownership

Insider Ownership0.44%
Institutional Ownership91.57%
Shares Short5.53M

High institutional ownership with low short interest suggests steadier hands and low immediate risk.

Analyst Sentiment & Price Targets

Mean Target
$292.94
Upside Potential
-0.8%
Recommendation
hold
The stock is trading above the mean analyst target of $292.94, suggesting it may be fully valued relative to current consensus estimates.

Earnings snapshot

Next report Oct 21, 2026 (before the open)

EPS beat rate
83% (10/12)
Avg move after earnings
±1.5%
Options-implied move
±4.0%
Options vs history
Expensive
CME earnings history, charts and expected move

Frequently Asked Questions

Common investor questions about CME Group Inc.

CME Group Inc. (CME) is currently trading at $295.31. The RSI (14-day) is at 77.1, indicating overbought territory (potentially overheated). Wall Street analysts have a consensus "hold" recommendation. The mean analyst price target of $292.94 implies 0.8% downside from current levels. Volatility is low at 17.1% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.

Based on current valuation metrics for CME Group Inc. (CME): The trailing P/E ratio is 23.77, which is in line with broader market averages. The forward P/E is 22.08, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 4.93, above 2.0, suggesting the stock may be overvalued relative to its expected growth. Price-to-Book is 3.80. Price-to-Sales is 14.92. Valuation should be compared to Financial Data & Stock Exchanges industry peers for context, as different sectors trade at different multiples.

Based on 16 analysts covering CME, the consensus price target is $292.94. This represents a 0.8% downside from the current price of $295.31. The range spans from a low target of $218.00 to a high target of $337.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "hold". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.

Yes, CME Group Inc. (CME) pays a dividend with a current yield of approximately 1.87%. The annualized dividend rate is $5.10 per share. The payout ratio is 95.4%, which is relatively high—earnings cover the dividend but there's limited room for increases. The most recent ex-dividend date was Sep 9, 2026.

Key risks for CME Group Inc. (CME) investors include: 1. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 2. Financial Data & Stock Exchanges sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.

Here is CME Group Inc.'s (CME) current debt and financial health profile: Total debt stands at $3.87B. The debt-to-equity ratio is 0.15x, which is conservative and indicates a strong balance sheet with low leverage. The current ratio is 1.02, indicating adequate short-term liquidity. The quick ratio is 0.02. The company holds $2.28B in cash and equivalents. Free cash flow is positive at $2.91B, providing a cushion for debt servicing and shareholder returns.